Merck, Takeda Unit Sue Fresenius Over Snake-Venom Drug

Merck & Co. and Takeda Pharmaceutical Co.’s Millennium unit sued subsidiaries of Fresenius SE for infringing three U.S. patents for a human blood-thinner made from rattlesnake venom.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.